COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,093 Articles (22,658 medRxiv, 8,435 bioRxiv)

Most recent first Previous |  Page 324: Articles 3231-3240  | Next

Can we start to ignore the SARS-CoV-2 disease?
Nesteruk, I.
10.1101/2023.09.18.23295709 — Posted: 2023-09-18
Adherence Behaviors to Prevent COVID: The Role of Anxiety and Prosocial Behaviors
Corbera, S., Marin-Chollom, A. M.
10.1101/2023.09.18.23295630 — Posted: 2023-09-18
Evidence associating neutrophilia, lung damage, hyperlactatemia, blood acidosis, impaired oxygen transport, and mortality in critically ill COVID-19 patients
Ali, S. S.
10.1101/2023.09.17.558185 — Posted: 2023-09-18
Third dose COVID-19 mRNA vaccine enhances IgG4 isotype switching and recognition of Omicron subvariants by memory B cells after with mRNA but not adenovirus priming
Hartley, G. E., Fryer, H. A., Gill, P. A., Boo, I., Bornheimer, S. J., Hogarth, P. M., Drummer, H. E., O'Hehir, R. E., Edwards, E. S. J., van Zelm, M. C.
10.1101/2023.09.15.557929 — Posted: 2023-09-18
A highly divergent SARS-CoV-2 lineage B.1.1 sample in a patient with long-term COVID-19
Nabieva, E., Komissarov, A. B., Klink, G. V., Zaitsev, S. V., Sergeeva, M., Fadeev, A. V., Komissarova, K., Ivanova, A., Pisareva, M., Kudrya, K., Danilenko, D., Lioznov, D., Hisner, R., Gueli, F., Peacock, T. P., Roemer, C., Bazykin, G. A.
10.1101/2023.09.14.23295379 — Posted: 2023-09-17
Complete substitution with modified nucleotides suppresses the early interferon response and increases the potency of self-amplifying RNA
McGee, J. E., Kirsch, J. R., Kenney, D., Chavez, E., Shih, T.-Y., Douam, F., Wong, W. W., Grinstaff, M. W.
10.1101/2023.09.15.557994 — Posted: 2023-09-17
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody
Phan, T., Zitzmann, C., Chew, K. W., Smith, D. M., Daar, E. S., Wohl, D. A., Eron, J. J., Currier, J. S., Hughes, M. D., Choudhary, M. C., Deo, R., Li, J. Z., Ribeiro, R. M., Ke, R., Perelson, A. S.
10.1101/2023.09.14.557679 — Posted: 2023-09-17
Temporal profiling of human lymphoid tissues reveals coordinated defence to viral challenge
Coates, M. L., Richoz, N., Tuong, Z. K., Bowyer, G., Lee, C. Y. C., Ferdinand, J. R., Gillman, E., McClure, M., Di Marco Barros, R., Stewart, B. J., Clatworthy, M. R.
10.1101/2023.09.15.558006 — Posted: 2023-09-17
VirEvol platform:accurate prediction and visualization of SARS-CoV-2 evolutionary trajectory based on protein language model, structural information and immunological recognition mechanism
Zheng, X., Zhang, L., Ning, Z., Qiu, Y., Dong, R., Li, X., Lv, L., Xu, H., Wang, Y., Ma, B.
10.1101/2023.09.15.557978 — Posted: 2023-09-17
Assessing the impact of the Gamma variant on COVID-19 Patient admissions in a Southern Brazilian tertiary hospital - A comparison of dual pandemic phases
Domino, N. R., Lapinscki, B. A., Zhen, F., Yamaguto, G., Costa, E. C. S., Moriya, V. L., Pereira, L. A., Petterle, R., Nogueira, M. B., Raboni, S. M.
10.1101/2023.09.13.23295114 — Posted: 2023-09-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).